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Abstract
Objective: Acute mitral stenosis (MS) following mitral valve (MV) repair is a rare but severe complication. We hypothesize
that intraoperative echocardiography can be utilized to diagnose iatrogenic MS immediately after MV repair.
Methods: The medical records of 552 consecutive patients undergoing MV repair at a single institution were reviewed. Post-
cardiopulmonary bypass peak and mean transmitral pressure gradients (TMPG), and pressure half time (PHT) were obtained
from intraoperative transesophageal echocardiographic (TEE) examinations in each patient.
Results: Nine patients (9/552=1.6%) received a reoperation for primary MS, prior to hospital discharge. Interestingly, all of
these patients already showed intraoperative post-CPB mean and peak TMPGs that were significantly higher compared to
values for those who did not: 10.764.8 mmHg vs 2.961.6 mmHg; p,0.0001 and 22.967.9 mmHg vs 7.663.7 mmHg;
p,0.0001, respectively. However, PHT varied considerably (87637 ms; range: 20–439 ms) within the entire population, and
only weakly predicted the requirement for reoperation (113656 vs. 87637 ms, p=0.034). Receiver operating characteristic
curves showed strong discriminating ability for mean gradients (AUC=0.993) and peak gradients (area under the curve,
AUC=0.996), but poor performance for PHT (AUC=0.640). A value of $7 mmHg for mean, and $17 mmHg for peak TMPG,
best separated patients who required reoperation for MS from those who did not.
Conclusions: Intraoperative TEE diagnosis of a peak TMPG $17 mmHg or mean TMPG $7 mmHg immediately following
CPB are suggestive of clinically relevant MS after MV repair.
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Introduction
Mitral valve repair has become the procedure of choice for
patients with significant MV dysfunction of most etiologies [1,2].
Repair of the MV is reportedly superior to replacement since it is
associated with better preservation of valve tissue, subvalvular
apparatus and left ventricular function, as well as improved long-
term survival [3,4]. Furthermore, MV repair permits greater
protection from endocarditis, thomboembolism and anticoagula-
tion-related morbidity [5,6].
Recurrent mitral regurgitation (MR) is well recognized as the
most common cause for failure of MV repair [7,8]. Another less
common complication is the development of late mitral stenosis
after MV repair especially for rheumatic disease [9] but also after
MV repair for non-rheumatic MR [10]. Ibrahim et al. reported a
1% incidence of late MS, manifesting 3–9 years after MV repair
for non-rheumatic MR [10]. Direct inspection of the MV repair in
patients who underwent reoperation in this study revealed
hindered, free leaflet motion associated with pannus formation
on the anuloplasty ring[10]. In contrast to the development of late
MS there is little information available on acute MS immediately
following MV repair. In a case study, Maslow et al. reported the
occurrence of a mitral stenosis immediately after mitral valve
repair in a 37 year old female patient with myxomatous mitral
valve disease [11]. In addition, an earlier study of Muratori et al.
reported an incidence of a single case of intraoperatively diagnosed
acute mitral stenosis out of a group of 142 patients also with
myxomatous mitral valve disease who underwent mitral valve
repair [12]. However, systematic reports of acute MS after MVP
in larger cohorts of patients have not been published.
Echocardiography is commonly used to diagnose and quantify
primary, native MS. Well established diagnostic criteria include
amongst others planimetry, gradient measurements and estimation
of pressure half-times [13]. However, alterations in MV orifice
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after cardiopulmonary bypass (CPB) were shown to influence the
intra- and postoperative echocardiographic evaluation of MS
[14,15]. The calculation of mitral valve area by pressure half time
measurements immediately after mitral valve repair was shown to
underestimate the actual mitral valve area [15]. This led to the
question which echocardiographic indices of MS severity still
provide reliable information in the intraoperative setting, since
specific echocardiographic criteria for the diagnosis of acute MS
after MV repair have not been well established.
Intraoperative echocardiography is commonly used in the
management of cardiac surgical patients [16,17]. In fact,
intraoperative echocardiographic diagnosis of MS following MV
repair would be desirable, since it would permit prompt surgical
revision before the development of postoperative morbidity and
mortality. Therefore, we retrospectively analyzed the medical
records and intraoperative, transesophageal (TEE) Doppler
echocardiographic examinations of patients undergoing MV
repair for MR, to determine specific echocardiographic criteria
for defining significant acute MS.
Methods
Patient Population
The study population consisted of all patients undergoing MV
repair for MR at the Brigham and Women’s Hospital between
2001 and 2003 of whom a post-CPB, transmitral Doppler flow
velocity profile was obtained and recorded for off-line analysis. 247
patients out of 552 were diagnosed with ischemic MR, 164 with
myxomatous degenerative mitral valve disease, 27 with rheumatic
heart disease and 17 patients were diagnosed with endocarditis
leading to MR. All patients were consented for an intraoperative
TEE during preoperative interview. Consent was given in written
form. The approval for this retrospective study was obtained from
the Institutional Review Board, Brigham and Women’s Hospital,
to review the patients’ medical records and intraoperative TEE
examination reports.
Echocardiographic Data
Comprehensive intraoperative TEE examinations were per-
formed using multiplane probes (Siemens, Mountain View, CA;
Philips Healthcare, Inc, Andover, MA). All TEE examinations
were performed by cardiac anesthesiologists with extensive
experience in perioperative echocardiography. Peak and mean
TMPGs were determined using the simplified Bernoulli Equation
from either pulse wave Doppler flow velocities (PWD) obtained at
the tips of the mitral leaflets, or continuous wave Doppler to
identify transmitral velocities when aliasing occurred despite
optimal adjustment of the scale and baseline. TEE examinations
were recorded on super VHS tape and analyzed off-line by a
cardiac anesthesiologist (H.K.E.) and a cardiologist (R.B.) with
extensive experience in perioperative echocardiography. Both
examiners were blinded to the clinical outcome data. Analysis of
the echocardiographic data included calculations of the peak and
mean TMPG, and PHT from the post-CPB transmitral Doppler
flow velocity profiles. Values for mean and peak TMPG and PHT
were obtained from the average of three separate measurements.
Decision to return to CPB to re-do the mitral valve repair
The decision to return to CPB to revise the original MV repair
or replace the valve was made on an individual basis for each
patient and included the following standard considerations: (a) the
degree of hemodynamic instability (b) the patient’s co-morbidity (c)
potential additional morbidity associated with a prolonged second
period of CPB (d) the surgeons’ opinion as to their ability to
produce a better result (e) echocardiographic findings, particularly
from 2D echocardiography suggestive of MS (e.g. restricted leaflet
mobility). Leaflet restriction was reported, but not objectively
quantified, by the cardiac anesthesiologists who performed the
intraoperative TEE examination. While echocardiographic mea-
surements of TMPGs were available, cut-off values indicating
significant acute iatrogenic MS following MV repair were not
known at the time of this study.
Review of Medical Records and Follow-Up
Medical records were reviewed for patients’ demographics, type
of surgical procedure and MV repair, and the incidence and
indication for MV reoperation prior to hospital discharge.
Statistical Analyses
Demographic data were tabulated and descriptive statistics
calculated. The echocardiographic data from the two independent
analyses were averaged. Interobserver variability was assessed with
Pearson correlation, and r and 95% confidence interval were
calculated. Mean values for echocardiographic parameters were
compared by unpaired t-test. Receiver operating characteristic
(ROC) curves, area under the curve (AUC) and standard error
(SE) were calculated with the use of the Graph Pad Prism 5
software. Values for best discrimination of cases requiring and not
requiring reoperation were estimated by inspection. When exact P
values were not specified, P,0.05 was considered significant.
Results
Patient Population
A total of 552 patients who underwent MV repair were included
in the analysis. An additional 26 patients did not have
interpretable Doppler recordings. Demographic data, type of
surgical procedure and a description of the MV repair are
displayed in Table 1. Nine (9/552=1.6%) patients with
intraoperative TEE evidence of restricted MV leaflet motion
underwent reoperation for MS prior to hospital discharge,
including 4 patients who underwent surgical revision of the initial
MV repair immediately following the post-CPB echocardiographic
examination (Table 2). All of these patients were receiving
inotropic and pressor support while attempting to wean from
CPB following MV repair. None of these patients demonstrated
significant concurrent MR.
Interobserver Variability
Interobserver variability was excellent for both measures of
TMPG: Pearson’s r and 95% CI were 0.989 (0.987, 0.991) for
peak gradient and 0.964 (0.958, 0.970) for mean gradient. PHT
correlated less well between observers (r=0.263 [0.183, 0.340]).
All correlations were highly significant (P,0.0001).
Transmitral Pressure Gradients and Pressure Half-Time
Mean and peak postoperative TMPGs for the entire population
(mean 6 SD) were 3.162.0 mmHg and 7.664.2 mmHg
respectively. Patients with restricted MV leaflet motion by post-
CPB intraoperative TEE who did not have persistent significant
MR and required a MV reoperation for MS, had a mean TMPG
of 10.764.8 mmHg vs. 2.961.6 mmHg without MS and had a
peak TMPG of 22.967.9 mm Hg vs. 7.663.7 mmHg without MS
(P,0.0001 for each comparison) measured by intraoperative TEE.
All of these patients were discharged from the hospital. PHT
varied considerably (87637 ms; range: 20–439 ms) and only
weakly predicted a requirement for reoperation (113656 vs.
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and PHT are shown in Figures 1, 2, and 3, respectively. The AUC
(SE) for pressure gradients showed strong discriminating ability for
both peak TMPG (0.996 [0.003]) and mean TMPG (0.993
[0.003]), but much weaker ability for PHT (0.640 [0.092]).
Values for separation of cases requiring reoperation for MS
from those that did not were estimated by inspection of the
distribution of peak and mean TMPG values (Figure 3). A peak
gradient of $17 mmHg, or mean gradient of $7 mmHg, best
separated these patients.
Discussion
The development of MS following MV repair is most
commonly associated with late degenerative changes and fibrous
overgrowth, which restrict diastolic leaflet excursion over the time
[10,18]. In contrast, acute MS following with mitral valve repair
surgery can present intraoperatively, immediately after the
termination of CPB. The exact incidence however remains
unknown, as previous reports are either single case reports [11]
or are based only on small numbers of patients [12] and studies in
different centers might be highly influenced of patient heteroge-
neity. Here, we used intraoperative TEE to identify a peak or
mean TMPG of at least 17 mmHg or 7 mmHg, respectively, as
indicators of significant early MS in 9 out of 552 patients who
subsequently required prompt surgical revision following an initial
MV repair for primary MS. All of these patients survived to be
discharged from the hospital. Thus, intraoperative TEE may be
useful for accurately and efficiently identifying patients with acute
MS following MV repair who may benefit from a prompt surgical
revision before the development of significant postoperative
morbidity and mortality.
Intraoperative ultrasound and TEE is a widely used, safe and
practical technique [17,19–34]. TEE can be used for the
intraoperative evaluation of the mitral valve [17,35], including
evaluation for MS severity [36]. However, two-dimensional
echocardiographic diagnosis of MS following post-MV repair
may be difficult in some patients including those undergoing an
Alfieri edge-to-edge repair in which the mid-portion of the
anterior and posterior leaflet are intentionally sutured together to
prevent MR [37]. Interestingly, although 3 of the 9 patients in our
series who required reoperation for MS initially underwent edge-
Table 1. Patient Characteristics and Surgical Procedure
(N=552).
Age 63.3614.1
Gender 188 F/364 M
Surgical procedure
Primary Reoperation
MV Repair 203 10
MV Repair + CABG 226 20
MV Repair + other valve (AVR, TVR) 45 15
MV Repair + other valve (AVR, TVR) + CABG 33 0
Type of Repair
Isolated Annuloplasty 453
Annuloplasty + Leaflet Resection 6
Annuloplasty + Chordal Repair 1
Annuloplasty + Commisurotomy 1
Annuloplasty + Maze procedure 1
Annuloplasty + Pericardial Patch 1
Isolated Alfieri (‘‘edge-to-edge’’) 29
Alfieri (‘‘edge-to-edge’’) + Leaflet Resection 1
Alfieri (‘‘edge-to-edge’’) + Commisurotomy 1
Alfieri (‘‘edge-to-edge’’) + Chordal Repair 1
Alfieri (‘‘edge-to-edge’’) + Ring Annuloplasty 49
Ring Annuloplasty + Leaflet Resection + Alfieri Stitch 3
Other 5
Rings used for annuloplasty
Carbomedics 12
Carpentier-Edwards 181
Cosgrove-Edwards 341
Duran 7
Medtronic 1
No ring 37
yr: years; M/F; Male/Female; CABG: coronary artery bypass grafting, MV: mitral
valve, AVR: aortic valve replacement, TVR: tricuspid valve repair.
doi:10.1371/journal.pone.0026559.t001
Table 2. Characteristics of Patients with Mitral Stenosis after Mitral Valve Repair.
Age M/F MR Etiology Primary Procedure
P/M
(mmHg)
Reoperation
Time
Reoperation
Type LOS (d)
D/C
y/n
67 M Ischemic MR CABG, AVR, Alfieri 22/12 Post CPB Alfieri Revision 13 y
54 F Myxomatous # 38 C-E-P 38/22 Post CPB MVP Revision 7 y
39 M Myxomatous # 30 CG 19/7 2 d # 36 CG 6 y
69 M Myxomatous # 28 CG, CABG 17/7 Post CPB MVR # 29 Hancock 10 y
36 F Myxomatous Endocarditis # 34 CG, Alfieri 18/10 1 d MVR # 31 St Jude 22 y
76 F Ischemic MR # 26 C-E-P 21/11 Post CPB MVR # 27 C-E-P 20 y
52 F Myxomatous # 26 C-E-P, Alfieri 31/12 8 d # 28 CM Annuflex Ring 15 y
77 F Myxomatous # 28 MT Ring 17/7 6 d MVR #29 Hancock 7 y
54 F Myxomatous #32 CG, Alfieri 19/7 12 h Alfieri Revision 7 y
M/F: Male/Female; MR: mitral regurgitation; P/M: peak and mean transmitral mitral pressure gradients obtained by post-CPB, intraoperative transesophageal
echocardiography; LOS: length of hospital stay; d:days; h:hours; D/C: discharge from hospital; y: yes; n: no; MVP: mitral valve repair; MVR: mitral valve replacement; CPB:
cardiopulmonary bypass; AVR: aortic valve replacement; CABG: coronary artery bypass grafting; CG: Cosgrove-Edwards annuloplasty; C-E-P: Carpentier Edwards ring
annuloplasty; MT: Medtronic; CM: Carbo Medics.
doi:10.1371/journal.pone.0026559.t002
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PLoS ONE | www.plosone.org 3 November 2011 | Volume 6 | Issue 11 | e26559Figure 1. Distribution of peak gradients, split by the requirement for reoperation for mitral stenosis (MS). (A) A peak gradient of
$17 mm Hg, best separated cases requiring reoperation for MS from those that did not. (B) Receiver operator curves (ROC) for peak transmitral
pressure gradients. The area under the curve (AUC [SE]) for peak transmitral pressure gradients (0.996 [0.003]) showed strong discriminating ability.
doi:10.1371/journal.pone.0026559.g001
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PLoS ONE | www.plosone.org 4 November 2011 | Volume 6 | Issue 11 | e26559Figure 2. Distribution of mean gradients, split by the requirement for reoperation for mitral stenosis (MS). (A) A mean gradient of
$7 mm Hg, best separated cases requiring reoperation for MS from those that did not. (B) Receiver operator curves (ROC) for mean transmitral
pressure gradients. The area under the curve (AUC [SE]) for mean transmitral pressure gradients (0.993 [0.003]) showed strong discriminating ability.
doi:10.1371/journal.pone.0026559.g002
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PLoS ONE | www.plosone.org 5 November 2011 | Volume 6 | Issue 11 | e26559Figure 3. Distribution of pressure half times after mitral valve repair. (A) Distribution of pressure half times showed no significant difference
in distribution between cases requiring reoperation for MS and those that did not. (B) Receiver operator curve (ROC) for pressure half time (PHT). The
area under the curve (AUC [SE]) showed only weak discriminating ability (0.640 [0.092]).
doi:10.1371/journal.pone.0026559.g003
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significantly decrease MR by reducing MV area while maintaining
mean TMPG,6 mmHg [37] and preserving MV reserve [38].
Classical Doppler echocardiographic measures for quantifying
native MS may not be applicable immediately following MV
repair due to acute changes in orifice geometry and chamber
compliance [14]. Limitations in using Doppler echocardiography
to assess MS severity have been described in patients undergoing
mitral valvotomy. Although Hatle et al. demonstrated a reliable,
inverse correlation between Doppler echocardiographic measure-
ments of PHT and MV orifice area in patients with native MS
[38], the same correlation between PHT and MV area could not
be demonstrated in patients with MS immediately after mitral
valvotomy [14]. Similarly, while Maslow et al. demonstrated good
agreement and correlation between MV area with PHT and
planimetry obtained with two-dimensional echocardiography in
patients undergoing MV repair [39], others have shown that
intraoperative TEE measurement of PHT following MV repair
may be unreliable and can underestimate MV area [15]. In our
study, PHT varied considerably and only weakly predicted a
requirement for reoperation, suggesting that PHT may be
dependent upon hemodynamic variables other than MV orifice
area including net left atrial and ventricular compliance [14].
Estimating MV area using the PISA technique hs been
demonstrated in patients with native MS, and has been used to
estimate mitral regurgitant orifice area following MV surgery [40].
However, PISA has not been consistently validated for assessing
acute MS immediately after MV repair. Furthermore, the
estimation of MV area using the PISA technique may be relatively
time consuming, and therefore impractical to apply in the
immediate post-CPB period while a hemodynamically unstable
patient is being resuscitated.
Finally, 3D echocardiography is a rapidly evolving technique
which is increasingly used intraoperatively during mitral valvuloplasty
[41] and mitral valve repair [42]. In primary, native mitral stenosis,
estimationofMVAwith3Dechocardiographyisconsideredtobethe
gold standard of diagnosis of mitral stenosis by some authors [43].
However, until now, no study is available which examined the
reliability of 3D TEE MVA measurements in identifying acute MSin
the intraoperative setting immediately after MVP.
Alternatively, as demonstrated in the present study, TMPGs
obtained by Doppler echocardiography are reliable measures of MS
severity,highlyreproducible,easy to acquireandshould thereforebe
considered an important component of the post-CPB intraoperative
echocardiographic examination in patients undergoing MV surgery.
Echocardiographic calculation of TMPG as a measure of MS
severity may be influenced by the presence of concurrent MR
[44]. None of the patients in our study who required reoperation
for significant MS demonstrated concurrent significant MR.
Conventional echocardiographic measures of MS severity may
also be influenced by changes in cardiac output. Mohan et al. used
dobutamine stress echocardiography in 57 ambulatory patients
with MS to show that alterations in transmitral flow are associated
with small and clinically insignificant changes in directly
planimetered MV area, but more pronounced changes in MV
as determined by PHT [45]. In addition, Firstenberg et al. also
used stress echocardiography in 13 patients with MS to
demonstrate that changes in cardiac output result in predictable
changes in PHT [46]. Although increases in cardiac output may
promote MV orifice stretching and reserve associated with
decreases in PHT, increased flow rates may also be associated
with higher TMPGs [46]. All patients with significant MS in our
study who eventually underwent surgical revision were hemody-
namically compromised and were receiving inotropic and pressor
support, however intraoperative cardiac output was not routinely
measured during the post-CPB echocardiographic examination.
Therefore, we were unable to determine the specific influence of
cardiac output on echocardiographic measures of MS severity.
Nonetheless, direct and indirect echocardiographic measures of
MV area appear to remain valid under conditions of varying
transmitral flow [45,46]. Finally, Doppler echocardiographic
measures of MS severity may also be influenced by changes in
diastolic function including impaired LV relaxation and compli-
ance. However, all of the patients in our study with a presumed
diagnosis of acute MS post MV repair had echocardiographic
evidence of restricted MV leaflet motion, and furthermore, it is
uncommon for peak TMPG to exceed 17 mmHg due to isolated,
impaired LV compliance.
Intuitively, one might expect to see a higher prevalence of
iatrogenic MS in patients undergoing MV repair for ischemic MR
using a relatively restrictive annuloplasty compared to surgical
approaches for repairing degenerative etiologies of MR. However,
in our series, patients who underwent only annuloplasty ring
placement for ischemic or functional MR seemed less susceptible to
acuteMS afterMVP(2 out of 247 patients)perhapsduetoextensive
surgical experience in sizing rings. On the other hand, patients with
myxomatous MV disease were more likely to require repairs that
involved increased complexity associated with leaflet resection and
reconstruction including edge-to-edge repairs. This might have
beenthe reasonforthe increaseinincidenceofacuteMSafterMVP
of myxomatous valves (6 out of 164 patients). Moreover, this might
underline the benefit of intraoperative measurement of TMPGs
especially during MVPs of myxomatous mitral valves.
Some important limitations of the present studies should be
noted. The present findings are somewhat confounded by the
availability of Doppler data in an un-blinded fashion during
surgery, such that the decision to revise the original MV repair
may have been partly based on the echocardiographic findings.
Thus, the lack of independence between the measure and the
outcome has the potential to overestimate the strength of the
relationships. Secondly, transmitral flow measurements are flow
dependent and the present study did not include the integration of
flow measurements into the assessment of MS severity. Thirdly,
despite the large number of patients that were included in the
present study, only a relatively small number of patients were
diagnosed with significant MS. Therefore, prospective studies
utilizing flow dependent measures of MS severity following MV
repair and including a greater number of patients with iatrogenic
MS are warranted to validate these results.
In conclusion, elevated mean and peak TMPGs obtained in the
post-CPB period are practical and reliable indicators of significant
MS immediately following MV repair. However, these values
should not necessarily be considered pathognomonic for isolated
perioperative MV dysfunction. Nonetheless, identifying an
increased TMPG following MV repair should alert the intraop-
erative echocardiographer to consider acute MS especially in the
presence of concurrent hemodynamic instability, and may allow
the cardiac surgeon to consider a prompt revision prior to the
development of significant postoperative morbidity and mortality.
Further study is warranted to prospectively evaluate the impact of
both intraoperative TEE Doppler derived gradient pressures and
3D TEE indices of MV area on perioperative surgical decision
making in patients undergoing valve MV repair [47,48].
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